Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year Here’s what a complete fund exit reveals about sentiment toward one of biotech’s endocrine drug developers.
Here's Why One Fund Just Bet $46 Million on This Surging Printed Circuit Board Stock One semiconductor supplier’s surge in institutional demand is revealing where smart money expects the next leg of tech growth to unfold.
2025: The Year Of Alphabet No stock has seen a bigger jump recently than Alphabet, whose market cap has risen by more than half of a trillion dollars since 10/29.
Why JPMorgan Believes Oil Could Crash To $30 Over The Next Two Years While global oil demand is expected to rise steadily – by nearly 900,000 barrels per day in 2026 and 1.2 million barrels per day in 2027 – production is forecast to grow at triple that rate.
Top Reasons Tilray Stock Price Has More Downside To Go Tilray stock price has attempted to rebound this week as it rose in the last three consecutive days.
The FTSE Finish Line - Thursday, Nov. 27 The UK's FTSE 100 hugged the flatline on Thursday, weighed down by losses in the consumer staples and energy sectors.
Invest In U.S. Exceptionalism Private investments in U.S. tech companies in the first nine months of this year rose 95% to $177bn compared with a 7% increase to $33bn in the EU.
This Small-Cap Consumer Stock Has Landed New Institutional Backing as Shares Surge 60% A fast-growing niche segment may be the real reason this small-cap consumer products stock is drawing new institutional attention.
Visa Partners With Aquanow To Boost Stablecoin Use Across CEMEA Visa partners with Aquanow to expand USDC stablecoin settlements across CEMEA, aiming for faster, cheaper cross-border payments.
Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% Harrow’s accelerating revenue and expanding product portfolio may help explain why a fundamentals-focused investment firm just made it a new position.
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys One small fund’s high-conviction move offers a window into how specialists are navigating 2025’s biotech rally.
Silver Price Consolidates As USD Rebounds, Fed Rate Cut Outlook Supports Demand Silver (XAG/USD) drifts slightly lower on Thursday, trading around $53.25, down 0.15% on the day at the time of writing.
SEC Opens Civil Probe Into Jefferies Over $12B First Brands Collapse The SEC is investigating Jefferies over its disclosures tied to First Brands' $12B collapse, as CEO claims the firm was defrauded.
3 Dividend-paying Stocks That Are Up Over 30% In 2025 AbbVie, Amgen, and IBM are among 2025’s top dividend performers, each up more than 30% while offering solid yields and steady income.
